You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Details for Patent: 7,214,506

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,214,506 protect, and when does it expire?

Patent 7,214,506 protects JUBLIA and is included in one NDA.

This patent has thirteen patent family members in eleven countries.

Summary for Patent: 7,214,506

Title:	Method for treating onychomycosis
Abstract:	A novel method for evaluating an effect of an antimicrobial agent which comprises removing the antimicrobial agent remaining in a biological sample or the like to thereby accurately evaluate the effect of the antimicrobial agent without being affected by the remaining antimicrobial agent. A therapeutic agent for onychomycosis which can be obtained according to the evaluation method of the drug effect.
Inventor(s):	Tatsumi; Yoshiyuki (Otsu, JP), Yokoo; Mamoru (Otsu, JP), Nakamura; Kosho (Moriyama, JP), Arika; Tadashi (Suita, JP)
Assignee:	Kaken Pharmaceutical Co., Ltd. (Bunkyo-ku, Tokyo, JP)
Application Number:	10/685,266
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,214,506
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,214,506

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch	JUBLIA	efinaconazole	SOLUTION;TOPICAL	203567-001	Jun 6, 2014	AB	RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,214,506

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	11/214369	Jul 28, 1999

International Family Members for US Patent 7,214,506

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	434667	⤷ Try a Trial
Australia	5852400	⤷ Try a Trial
Canada	2391274	⤷ Try a Trial
Cyprus	1109281	⤷ Try a Trial
Germany	60042453	⤷ Try a Trial
Denmark	1205559	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.